Vir Biotechnology and Biogen Execute Agreement to Manufacture SARS-CoV-2 Antibodies for Potential COVID-19 Treatment

    NEXT STORY
    CytomX Therapeutics Clinical Programs Highlighted at American Society of Clinical Oncology ASCO20 Virtual Scientific Program
    PREV STORY
    Autolus Therapeutics presents additional data on AUTO3 in DLBCL during the ASCO20 Virtual Scientific Program
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Point of Care Diagnostics Market to Reach USD 28,379.6 Million by 2026; Developing Healthcare facilities in India will Foster Growth, states Fortune Business Insights™

    author_avatar
    NASDAQ Market News

    Treos Bio Announces FDA Approval of IND of Its First PolyPEPI™ Precision Cancer Vaccine for Metastatic Colorectal Cancer

    SAN FRANCISCO and LONDON, Jan. 24, 2018 (GLOBE NEWSWIRE) -- Treos Bio Limited, an ...

    author_avatar
    NASDAQ Market News

    Cybrexa Therapeutics Expands Scientific Advisory Board Ahead of IND Filing

    Dr. Geoffrey Shapiro and Dr. Timothy Yap bring extensive expertise in targeting cell-cycle and ...

    author_avatar
    NASDAQ Market News